kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant SARS-CoV-2 (COVID-19) S protein (D614G), His Tag, Super stable trimer (MALS verified), 50µg  

Recombinant SARS-CoV-2 (COVID-19) S protein (D614G), His Tag, Super stable trimer (MALS verified), 50µg

Recombinant SARS-CoV-2 (COVID-19) S protein (D614G), Super stable trimer (MALS verified), expressed from human 293 cells (HEK293), His Tag

Synonyms: Recombinant, protein, Spike, S protein, Spike glycoprotein, S glycoprotein, COVID-19

More details


Availability: within 7 days

585,00 €

It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant SARS-CoV-2 S protein (D614G, R683A, R685A), His Tag, Super stable trimer (SPN-C52H3) is the ectodomain of SARS-CoV-2 S protein that contains AA Val 16 - Pro 1213 (Accession # QHD43416.1) and D614G mutation, which has become increasingly common in SARS-CoV-2 viruses from around the world . The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively.

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 138.0 kDa. The protein migrates as 170-200 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg by the LAL method.

>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Trehalose are added as protectants before lyophilization.

See Certificate of Analysis for reconstitution instructions and specific concentrations.

Please refer to product data sheet.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Clinical and Translational Updates

(1) "Regenerable and high-throughput surface plasmon resonance assay for rapid screening of anti-SARS-CoV-2 antibody in serum samples"
Jiang, Dong, Han et al
Anal Chim Acta (2022) 1208, 339830
(2) "Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: possible implications for SARS-CoV-2 impact on brain development"
Francesca, Mauro, Clerbaux et al
Reprod Toxicol (2022)
(3) "Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism"
Marais, Hsiao, Iranzadeh et al
J Clin Virol (2022) 152, 105170
Showing 1-3 of 20956 papers.


(1) "SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity"

Authors: Ozono S, Zhang Y, Ode H, et al.
Journal: Nature communications 2021
Application: BLI